DeepSADR: Deep Transfer Learning with Subsequence Interaction and Adaptive Readout for Cancer Drug Response Prediction

Cancer treatment efficacy exhibits high inter-patient heterogeneity due to genomic variations. While large-scale in vitro drug response data from cancer cell lines exist, predicting patient drug responses remains challenging due to genomic distribution shifts and the scarcity of clinical response data. Existing transfer learning methods primarily align global genomic features between cell lines and patients. However, they often ignore two critical aspects. First, drug response depends on specific drug substructures and genomic function subsequences. Second, drug response mechanisms differ in vitro and in vivo settings due to factors such as the immune system and tumor microenvironment. To address these limitations, we propose DeepSADR, a novel deep transfer learning framework for enhanced drug response prediction based on subsequence interaction and adaptive readout. In particular, DeepSADR models drug responses as interpretable bipartite interaction graphs between drug substructures and genomic function subsequences. Subsequently, a supervised graph autoencoder was designed to capture latent interactions between drugs and gene subsequences within these interaction graphs. In addition, DeepSADR treats the drug response process as a transferable domain. A Set Transformer-based adaptive readout (AR) function learns domain-invariant response representations, enabling effective knowledge transfer from abundant cell line data to scarce patient data. Extensive experiments on clinical patient cohorts demonstrate that DeepSADR significantly outperforms state-of-the-art methods, and ablation experiments have validated the effectiveness of each module.